DK3351936T3 - Cellemedieret immunresponsanalyse med forbedret følsomhed - Google Patents

Cellemedieret immunresponsanalyse med forbedret følsomhed Download PDF

Info

Publication number
DK3351936T3
DK3351936T3 DK18158828.6T DK18158828T DK3351936T3 DK 3351936 T3 DK3351936 T3 DK 3351936T3 DK 18158828 T DK18158828 T DK 18158828T DK 3351936 T3 DK3351936 T3 DK 3351936T3
Authority
DK
Denmark
Prior art keywords
cell
immune response
mediated immune
response analysis
improved sensitivity
Prior art date
Application number
DK18158828.6T
Other languages
English (en)
Inventor
Jeff Boyle
Original Assignee
Qiagen Australia Holding Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47423289&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3351936(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Qiagen Australia Holding Pty Ltd filed Critical Qiagen Australia Holding Pty Ltd
Application granted granted Critical
Publication of DK3351936T3 publication Critical patent/DK3351936T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK18158828.6T 2011-06-29 2012-06-27 Cellemedieret immunresponsanalyse med forbedret følsomhed DK3351936T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161502811P 2011-06-29 2011-06-29
EP12804281.9A EP2726883B2 (en) 2011-06-29 2012-06-27 A cell mediated immune response assay with enhanced sensitivity

Publications (1)

Publication Number Publication Date
DK3351936T3 true DK3351936T3 (da) 2025-03-10

Family

ID=47423289

Family Applications (2)

Application Number Title Priority Date Filing Date
DK12804281.9T DK2726883T4 (da) 2011-06-29 2012-06-27 Cellemedieret immunresponsanalyse med forbedret følsomhed
DK18158828.6T DK3351936T3 (da) 2011-06-29 2012-06-27 Cellemedieret immunresponsanalyse med forbedret følsomhed

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK12804281.9T DK2726883T4 (da) 2011-06-29 2012-06-27 Cellemedieret immunresponsanalyse med forbedret følsomhed

Country Status (22)

Country Link
US (3) US9983207B2 (da)
EP (3) EP4556906A3 (da)
JP (1) JP6150177B2 (da)
KR (1) KR102022513B1 (da)
CN (3) CN108593936B (da)
AU (5) AU2012276280B2 (da)
BR (1) BR112013033520B1 (da)
CA (1) CA2840484C (da)
CY (1) CY1120633T1 (da)
DK (2) DK2726883T4 (da)
ES (2) ES2673697T5 (da)
FI (1) FI3351936T3 (da)
HU (2) HUE037801T2 (da)
LT (2) LT2726883T (da)
MX (1) MX357717B (da)
PL (1) PL3351936T3 (da)
PT (2) PT2726883T (da)
RU (2) RU2647468C2 (da)
SI (2) SI3351936T1 (da)
TR (1) TR201808740T4 (da)
WO (1) WO2013000021A1 (da)
ZA (1) ZA201309155B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105079781B (zh) 2008-11-30 2018-07-20 免疫桑特公司 用于治疗乳糜泻的组合物和方法
JP2012167952A (ja) * 2011-02-10 2012-09-06 Central Automotive Products Ltd アルコール検知器
JP6150177B2 (ja) 2011-06-29 2017-06-21 セルスティス リミテッド 高感度細胞性免疫応答アッセイ
JP6123282B2 (ja) * 2012-12-20 2017-05-10 富士電機株式会社 プログラマブルコントローラおよび電源切断対処方法
AU2013370928B2 (en) * 2012-12-28 2019-05-02 Qiagen Sciences Llc A cell mediated immune response assay
JP2014229116A (ja) * 2013-05-23 2014-12-08 富士電機株式会社 プログラマブルコントローラおよび電源切断対処方法
EP3043812A1 (en) 2013-09-10 2016-07-20 Immusant Inc. Dosage of a gluten peptide composition
US10370718B2 (en) 2014-09-29 2019-08-06 Immusant, Inc. Use of HLA genetic status to assess or select treatment of celiac disease
US20170305976A1 (en) * 2014-10-23 2017-10-26 Qiagen Sciences, Llc Peptide composition and uses thereof
US20180267024A1 (en) 2015-06-08 2018-09-20 Lophius Biosciences Gmbh Composition for determination of cell-mediated immune responsiveness
GB201605210D0 (en) * 2016-03-29 2016-05-11 Oxford Immunotec Ltd Assay
AU2019253924A1 (en) * 2018-04-19 2020-11-26 StickyCell Pty Ltd Leukocyte recruitment in infectious disease
CN112513635B (zh) * 2018-05-11 2024-04-16 台湾浩鼎生技股份有限公司 预测人体免疫反应的方法
JP6796737B1 (ja) * 2020-06-02 2020-12-09 振武 曽 多項目自動血球計数装置
US20230314432A1 (en) * 2020-07-10 2023-10-05 Covid Diagnostics Ltd. Compositions, methods, and systems for detecting immune response
CN114062665B (zh) * 2020-08-05 2023-04-28 菲鹏生物股份有限公司 示踪粒子标记目标分子及其制备方法和应用
CN113238060B (zh) * 2021-05-08 2022-10-11 迈克生物股份有限公司 用于预测或诊断心肌炎的试剂盒
WO2024263622A1 (en) * 2023-06-19 2024-12-26 Immune Functional Diagnostics, Llc Methods and assays for immune phenotyping

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018653A (en) 1971-10-29 1977-04-19 U.S. Packaging Corporation Instrument for the detection of Neisseria gonorrhoeae without culture
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4424279A (en) 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
ID29858A (id) 1998-11-04 2001-10-18 Isis Innovation Uji diagnostik tuberkulosis
US20020131976A1 (en) † 1998-12-23 2002-09-19 Ajit Lalvani Tuberculosis vaccine
KR20030032922A (ko) * 2000-02-24 2003-04-26 싸이트 테라피스 인코포레이티드 세포의 동시 자극 및 농축
AUPQ689900A0 (en) 2000-04-14 2000-05-11 Commonwealth Scientific And Industrial Research Organisation Bubble acoustics
DE50205223D1 (de) * 2001-10-02 2006-01-12 Mologen Ag Mittel zur verbesserung der immunantwort
US7604803B2 (en) * 2002-07-05 2009-10-20 Lipoxen Technologies Limited Method to enhance an immune response of nucleic acid vaccination
ITRM20040091A1 (it) 2004-02-19 2004-05-19 Istituto Naz Per Le Malattie Test immunologico rapido per la diagnosi ed il monitoraggio dell'infezione tubercolare.
AU2005250055B2 (en) 2004-06-02 2008-09-11 Adalta Pty Ltd Binding moieties based on shark IgNAR domains
EP2132569B1 (en) * 2007-03-16 2015-10-28 Cellestis Limited A cell-mediated immune response assay and kits therefor
KR20100067089A (ko) * 2007-08-30 2010-06-18 제넨테크, 인크. Ｔ 세포를 조정하기 위한 방법 및 조성물
EP2106803A1 (en) * 2008-04-04 2009-10-07 Fondazione Centro San Raffaele del Monte Tabor Method to design and uses of overlapping peptides for monitoring T-cell responses in HIV patients
US20110033377A1 (en) * 2008-04-23 2011-02-10 Healthlinx Limited Assay to detect a gynecological condition
AU2009273749B2 (en) * 2008-07-25 2016-04-21 Qiagen Sciences Llc A diagnostic method
JP5768060B2 (ja) 2009-12-23 2015-08-26 セレスティス リミテッド 細胞性免疫応答を測定するためのアッセイ
JP6150177B2 (ja) * 2011-06-29 2017-06-21 セルスティス リミテッド 高感度細胞性免疫応答アッセイ

Also Published As

Publication number Publication date
SI2726883T2 (sl) 2022-09-30
EP2726883B1 (en) 2018-03-28
FI3351936T3 (fi) 2025-03-17
PT3351936T (pt) 2025-02-03
BR112013033520A2 (pt) 2017-02-07
DK2726883T4 (da) 2022-08-22
CN103703375A (zh) 2014-04-02
AU2017213471A1 (en) 2017-08-31
RU2013154967A (ru) 2015-08-10
EP2726883B2 (en) 2022-05-18
ZA201309155B (en) 2015-03-25
US20250369968A1 (en) 2025-12-04
WO2013000021A1 (en) 2013-01-03
AU2019222928B2 (en) 2022-02-03
LT3351936T (lt) 2025-02-25
EP4556906A2 (en) 2025-05-21
AU2022202799A1 (en) 2022-05-19
CN103703375B (zh) 2018-04-10
DK2726883T3 (da) 2018-07-16
AU2012276280B2 (en) 2017-05-25
HUE070908T2 (hu) 2025-07-28
MX2013015259A (es) 2014-04-16
HUE037801T2 (hu) 2018-09-28
EP2726883A4 (en) 2015-02-18
SI3351936T1 (sl) 2025-05-30
AU2025200713A1 (en) 2025-02-20
CN108593936B (zh) 2022-05-13
EP3351936A1 (en) 2018-07-25
EP2726883A1 (en) 2014-05-07
JP6150177B2 (ja) 2017-06-21
ES2673697T5 (es) 2022-09-14
KR102022513B1 (ko) 2019-09-19
CN108593936A (zh) 2018-09-28
CN115144594A (zh) 2022-10-04
LT2726883T (lt) 2018-06-11
CY1120633T1 (el) 2019-12-11
RU2018107763A (ru) 2019-02-25
SI2726883T1 (en) 2018-06-29
CA2840484A1 (en) 2013-01-03
ES3009107T3 (en) 2025-03-26
TR201808740T4 (tr) 2018-07-23
US20140220601A1 (en) 2014-08-07
US20190101536A1 (en) 2019-04-04
AU2019222928A1 (en) 2019-09-19
ES2673697T3 (es) 2018-06-25
US9983207B2 (en) 2018-05-29
EP4556906A3 (en) 2025-08-06
CA2840484C (en) 2020-04-14
CN115144594B (zh) 2025-09-05
EP3351936B1 (en) 2025-01-08
PL3351936T3 (pl) 2025-05-05
KR20140066991A (ko) 2014-06-03
RU2018107763A3 (da) 2021-06-01
RU2647468C2 (ru) 2018-03-15
PT2726883T (pt) 2018-06-05
BR112013033520B1 (pt) 2021-03-09
JP2014521052A (ja) 2014-08-25
MX357717B (es) 2018-07-20
AU2012276280A1 (en) 2014-01-09
BR112013033520A8 (pt) 2018-07-17

Similar Documents

Publication Publication Date Title
DK3351936T3 (da) Cellemedieret immunresponsanalyse med forbedret følsomhed
DK3594672T3 (da) Analytsensor
LT4056105T (lt) Analitės jutiklių įrenginiai
EP2836960A4 (en) BIOMETRIC DETECTION
BR112014009251A2 (pt) sensor de tampão
DK2649468T3 (da) Ultralydsmåling
EP2672292A4 (en) RADIATION DETECTOR
DK2749179T3 (da) Gærekstrakt med smagsforstærkende virkning
FR2975488B1 (fr) Capteur
DE112012002058T8 (de) Ionenerfassung
EP2900475A4 (en) Drop detection
EP2890961A4 (en) ACOUSTIC SENSOR
BR112013033747A2 (pt) sensores
FR2999415B1 (fr) Sonde endo-ureterale amelioree
JP2011209285A5 (ja) 力測定システム
EP2776854A4 (en) REMOVABLE SENSOR MODULES
EP2712534A4 (en) PROBE
EP2811271A4 (en) INFRARED SENSOR
IL227954B (en) Terahertz detection cell
EP2726839A4 (en) SAMPLERS
EP2672272A4 (en) Analysis device
EP2765789A4 (en) TRANSDUCER
BR112013029333A2 (pt) detecção de nível
EP2693177A4 (en) INFRARED SENSOR
PL3745128T3 (pl) Test odpowiedzi immunologicznej pośredniczony przez komórki